MDNA-11

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameMDNA-11
Drug Alias NameMDNA-11MDNA11
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor beta chain agonists
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsSkin MelanomaSolid tumoursMicrosatellite instability-high cancer +[25
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPortugal +[7
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursMicrosatellite instability-high cancer +[25
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A